V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270008023 | 270004876 | 1.52 | 53.7 | Neo-adjuvant (N) | 2014-01-05 | 2014-02-04 | Capecitabine 35days + RT | N | Y | 270015776 | CAPECITABINE + RT |
| 270008024 | 270004877 | null | 102.7 | Disease modification (D) | 2016-06-22 | 2016-06-29 | CHLVPP | 02 | null | 270015777 | CHLVPP |
| 270008025 | 270012458 | 1.65 | 64 | Palliative (P) | 2017-10-18 | 2017-11-07 | FLUOROURACIL + IRINOTECAN | N | N | 270015778 | IRINOTECAN + MDG |
| 270008026 | 270012458 | 0 | 69 | Curative (C) | 2014-09-15 | 2014-09-18 | HD EuroNet-PHL-C1 OEPA | 2 | N | 270015778 | OEPA |
| 270008027 | 270012458 | 1.73 | 87.5 | Curative (C) | 2015-10-17 | 2015-10-17 | CHLVPP | N | N | 270015778 | CHLVPP |
| 270008028 | 270018831 | 1.54 | null | Palliative (P) | 2017-04-30 | 2017-04-30 | Irinotecan + Modified De Gramont | N | N | 270015781 | IRINOTECAN + MDG |
| 270008029 | 270004878 | 0 | 94 | Curative (C) | 2013-08-30 | 2013-08-31 | HD EuroNet-PHL-C1 OEPA | N | null | 270015782 | OEPA |
| 270008030 | 270004878 | 1.84 | 69 | Curative (C) | 2016-07-12 | 2016-07-17 | OEPA | N | N | 270015782 | OEPA |
| 270008031 | 270004879 | 1.49 | 81.3 | Curative (C) | 2013-12-17 | 2013-12-30 | Capecitabine 35days + RT | 02 | Y | 270015784 | CAPECITABINE + RT |
| 270008032 | 270004880 | 0 | 73 | null | 2013-04-25 | 2013-05-02 | OEPA | N | N | 270015785 | OEPA |
| 270008033 | 270012460 | 1.82 | 77.4 | null | 2013-09-06 | 2013-09-11 | CHLVPP | N | N | 270015789 | CHLVPP |
| 270008034 | 270012460 | 1.73 | 70.8 | null | 2017-01-01 | 2017-01-05 | CHLVPP | N | N | 270015789 | CHLVPP |
| 270008035 | 270012460 | 1.74 | 106.2 | Adjuvant (A) | 2017-03-20 | 2017-03-21 | CHLVPP | N | N | 270015789 | CHLVPP |
| 270008036 | 270004881 | 1.65 | 72.2 | Curative (C) | 2013-01-14 | 2013-01-21 | OEPA | N | N | 270015794 | OEPA |
| 270008037 | 270012461 | 1.79 | 69.7 | Adjuvant (A) | null | 2014-11-06 | CAPECITABINE + RT | N | null | 270015795 | CAPECITABINE + RT |
| 270008038 | 270004882 | 1.66 | null | Curative (C) | 2014-08-22 | 2014-08-29 | CHLVPP | 02 | N | 270015796 | CHLVPP |
| 270008039 | 270004883 | 0 | 66.8 | Curative (C) | 2013-04-02 | 2013-04-02 | OEPA | N | null | 270015798 | OEPA |
| 270008040 | 270004883 | 1.65 | 62.8 | Neo-adjuvant (N) | 2017-11-01 | 2017-11-03 | CAPECITABINE + RT | N | Y | 270015798 | CAPECITABINE + RT |
| 270008041 | 270015827 | 1.38 | 89 | Curative (C) | 2013-12-18 | 2013-12-18 | HD EuroNet-PHL-C1 OEPA | N | N | 270015802 | OEPA |
| 270008042 | 270015827 | 1.8 | 63 | Palliative (P) | 2016-09-24 | 2016-10-10 | Irinotecan + Modified De Gramont | 02 | N | 270015802 | IRINOTECAN + MDG |
| 270008043 | 270004884 | null | 90.6 | Curative (C) | 2017-04-15 | 2017-04-15 | HD EuroNet-PHL-C1 OEPA | null | N | 270015806 | OEPA |
| 270008044 | 270004885 | 1.75 | 61.3 | Curative (C) | 2013-01-13 | 2013-01-24 | CHLVPP | 2 | N | 270015807 | CHLVPP |
| 270008045 | 270004886 | 1.66 | null | Curative (C) | 2014-08-30 | 2014-09-03 | OEPA | N | null | 270015810 | OEPA |
| 270008046 | 270004887 | null | 55 | Curative (C) | 2017-09-26 | 2017-09-30 | CHLVPP | N | N | 270015812 | CHLVPP |
| 270008047 | 270012463 | 1.71 | 56.7 | Curative (C) | 2016-02-04 | 2016-02-04 | OEPA | 2 | N | 270015813 | OEPA |
| 270008048 | 270012463 | 1.56 | null | null | 2016-02-01 | 2016-02-05 | Capecitabine 42days + RT | 02 | Y | 270015813 | CAPECITABINE + RT |
| 270008049 | 270004888 | 1.7 | 86 | Curative (C) | 2013-10-02 | 2013-10-25 | Capecitabine 35days + RT | 02 | Y | 270015815 | CAPECITABINE + RT |
| 270008050 | 270004889 | 1.69 | 83.7 | Neo-adjuvant (N) | 2015-07-11 | 2015-08-08 | Capecitabine 35days + RT | N | Y | 270015816 | CAPECITABINE + RT |
| 270008051 | 270004889 | 1.77 | 64.2 | Palliative (P) | 2016-06-13 | 2016-07-08 | Irinotecan + Modified De Gramont | N | N | 270015816 | IRINOTECAN + MDG |
| 270008052 | 270004889 | 1.75 | 56.2 | Curative (C) | 2017-04-05 | 2017-04-07 | HD EuroNet-PHL-C1 OEPA | N | N | 270015816 | OEPA |
| 270008053 | 270004890 | 1.66 | 57 | Neo-adjuvant (N) | 2018-03-19 | 2018-03-19 | Capecitabine 35days + RT | N | Y | 270015819 | CAPECITABINE + RT |
| 270008054 | 270004890 | 1.62 | null | Neo-adjuvant (N) | 2017-06-16 | 2017-07-14 | Irinotecan + Modified De Gramont | N | N | 270015819 | IRINOTECAN + MDG |
| 270008055 | 270004890 | 1.74 | 70 | Curative (C) | 2018-01-30 | 2018-02-20 | Capecitabine 42days + RT | null | Y | 270015819 | CAPECITABINE + RT |
| 270008056 | 270004891 | 1.58 | null | Neo-adjuvant (N) | 2016-10-16 | 2016-11-09 | CAPECITABINE + RT | N | Y | 270015822 | CAPECITABINE + RT |
| 270008057 | 270004892 | 1.88 | 78 | Neo-adjuvant (N) | 2014-08-06 | 2014-09-02 | Capecitabine 35days + RT | N | N | 270015823 | CAPECITABINE + RT |
| 270008058 | 270004893 | 1.74 | 39.6 | Curative (C) | 2015-03-22 | 2015-04-04 | CHLVPP | N | N | 270015824 | CHLVPP |
| 270008059 | 270004894 | 1.81 | null | Curative (C) | 2014-03-28 | 2014-04-03 | CHLVPP | N | N | 270015825 | CHLVPP |
| 270008060 | 270004894 | 1.57 | 20.8 | Palliative (P) | 2014-05-15 | 2014-05-29 | Irinotecan + Modified De Gramont | 2 | N | 270015825 | IRINOTECAN + MDG |
| 270008061 | 270004895 | 1.59 | 63.8 | Curative (C) | 2015-04-23 | 2015-04-23 | OEPA | N | N | 270015828 | OEPA |
| 270008062 | 270004895 | 1.64 | 70 | Curative (C) | 2017-12-04 | 2017-12-15 | CHLVPP | N | N | 270015828 | CHLVPP |
| 270008063 | 270004896 | 1.79 | 26.1 | Neo-adjuvant (N) | 2013-04-26 | 2013-05-24 | CAPECITABINE + RT | N | Y | 270015830 | CAPECITABINE + RT |
| 270008064 | 270004897 | 1.67 | null | Neo-adjuvant (N) | 2014-08-05 | 2014-08-07 | CAPECITABINE + RT | 02 | Y | 270015831 | CAPECITABINE + RT |
| 270008065 | 270004898 | 1.77 | 74.1 | Curative (C) | 2013-10-17 | 2013-10-21 | CHLVPP | N | N | 270015832 | CHLVPP |
| 270008066 | 270012468 | 1.84 | 92.1 | null | 2014-01-05 | 2014-01-05 | CHLVPP | N | N | 270015833 | CHLVPP |
| 270008067 | 270004899 | 1.81 | 78.8 | Curative (C) | 2017-09-11 | 2017-09-07 | OEPA | N | N | 270015834 | OEPA |
| 270008068 | 270004899 | 1.64 | 60.5 | Curative (C) | 2016-04-18 | 2016-04-22 | CHLVPP | N | N | 270015834 | CHLVPP |
| 270008069 | 270004899 | null | 65.2 | Curative (C) | 2014-05-16 | 2014-06-05 | OEPA | N | N | 270015834 | OEPA |
| 270008070 | 270004899 | 1.78 | null | Curative (C) | 2017-10-30 | 2017-11-06 | CHLVPP | N | N | 270015834 | CHLVPP |
| 270008071 | 270004900 | 1.6 | 74.7 | Palliative (P) | 2014-02-08 | 2014-02-10 | Irinotecan + Modified De Gramont | 02 | N | 270015839 | IRINOTECAN + MDG |
| 270008072 | 270004901 | null | 50 | Adjuvant (A) | 2014-08-28 | 2014-09-05 | HD EuroNet-PHL-C1 OEPA | N | N | 270015841 | OEPA |